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intimal-medial thickness (CIMT) is non-invasive modality used to evaluate
subclinical atherosclerosis and to predict future cardiovascular disease. The
objective of this study is to evaluate the association between apo B/A1 and
CIMT in chronic kidney disease (CKD).We retrospectively reviewed the 293
patients who had visited health promotion center in a single community.
The patients were divided into 2 group which are CKD group (n¼99,
estimated glomerular ﬁltration rate (eGFR): 15-59 mL/min) and non-CKD
group (n¼194, eGFR Z 60 mL/min). Age, sex, presence of diabetes mellitus
(DM)/hypertension, smoking status, eGFR, body mass index, and various
biochemical blood examinations (serum LDL/HDL cholesterol, serum
homocystein, and serum apo B/A1 ratio) were evaluated in each patient.
CIMT was measured by high-resolution B-mode ultrasonography.
Multivariate linear regression analysis was performed to investigate which
factors are associated with CIMT in each of 2 groups. In CKD group, age
(b¼0.163, p¼0.024), presence of hypertension (b¼0.208, p¼0.006), and
presence of DM (b¼0.236, p¼0.002) were independently associated with
CIMT adjustment for other confounding factors. However, in CKD group,
serum apo B/A1 (b¼0.572, po0.001), presence of HTN (b¼0.360,
p¼0.001), and presence of DM (b¼0.194 p¼0.023) contributed to CIMT
independently after adjustment for other confounding factors.
In conclusion, this study showed serum apo B/A1 ratio was
independently associated with CIMT only in CKD group, not in non-CKD
group. Because CIMT is a strong predictor of CVD, the result of this study
demonstrates serum apo B/A1 ratio could be included in cardiovascular
risk stratiﬁcation in CKD patients
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patients are considered to be physically less activity than normal, but there
are only few studies on this question. We measured DPA over 7 days, with the
new Actigraph GT3Xþ Activity Monitors, on 63 patients receiving MHD
3Xwk for Z6 months and 36 matched normals. Patients were 52714SD
years, 30% female; 35% diabetic; dialysis vintage, 61747 mos. Normals were
49712 years, 42% female, with similar racial/ethnic mix. The average daily
vector magnitude for DPA, calculated as the square root of the sum of the
squares of the three dimensional axes, was much lower in MHD, 398,868
counts (counts include HD days), vs. Normals (651,685 counts, Po0.001). In
MHD vs Normals, % time in sleep or marked physical inactivity was 81% vs
73% (Po0.001); % time in Zmoderate activity, 4.0% vs 7.0% (Po0.001). In
MHD, there was a trend toward increasing physical activity as patients
progressed from the HD day to one day and then two days post-HD (Two days
post-HD vs. HD day, p¼0.015). This trend might be due to reduced activity in
the HD unit, increased physical activity on weekends, or exhaustion from HD.
Thus, compared to matched normal adults, MHD patients have markedly
reduced DPA. Since study subjects had to be willing and able to complete
physical performance tests, the most debilitated MHD patients were not
recruited to the study. Hence, decreased DPA in MHD patients might be even
greater than observed.
http://dx.doi.org/10.1016/j.krcp.2012.04.442
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Bioimpedance analysis is a reliable technique for determining post dialysis
target weight. Using this technique, we can understand body ﬂuid status easier
and conveniently. Moreover this technique can be used for check nutrition
status and nutritional status of dialysis patients. We compared the body ﬂuid
status and nutrition status between hemodialysis (HD) patients and peritoneal
dialysis (PD) patients by BCM (Body composition monitor) technique. We
studied 48 (30 males and 18 females) PD patients, 21 (10 males and 11
females) HD patients. Body composition monitoring (BCM, Fesenitus Medical
Care, Germany) was used as a tool for the analysis of bioimpedance.
Extracellular water, Total body water, Intracellular water, Overhydration, E/I,
Lean tissue mass, Fat Tissue mass was measured and those results were
compared between two groups. HD patients were more hydrated than PD
patients (61.9% vs. 35.4%) and nutritional status such as LTI was poorer than
peritoneal dialysis patients (11.771.7 vs. 15.372.6). Although total body
water is more abundant in peritoneal patients (29.475.5L vs. 35.976.2L),
Extracellular water and intracellular water ratio was relatively higher in
Hemodialysis patients (E/I 0.9870.13 vs. 0.8770.12). The nutrition status was
better in PD patients by comparing the percent of lean tissue mass (LTM%)
between two groups (LTM% 52.1710.6% vs. 66.8711.3). In conclusions,
Hemodialysis patients were more hydrated with poorer nutrition status than
peritoneal dialysis patients, but, due to the signiﬁcant difference of age between
two groups, further study should be required.
http://dx.doi.org/10.1016/j.krcp.2012.04.443
120
THE CHALLENGE OF PD PATIENTS: GLUCOSE AND GLUCOSE
DEGRADATION PRODUCTS IN PD SOLUTION
Yong-Lim Kim
Division of Nephrology, Kyungpook National University Hospital., Daegu, Korea
The main osmotic agent found in the peritoneal dialysis (PD) solution is
glucose. It has been of a wide use for great crystalloid osmotic power at a low
concentration, simple metabolism, and excellent safety. On the other hand,
anywhere between 60 to 80% of the glucose in the PD solution is absorbed - a
100 to 300 mg of daily glucose absorption. Once into the systemic circulation,
glucose can be a cause for metabolic complications including obesity. Indeed,
the diabetiform change observed in the peritoneal membrane in the long-term
PD patients is believed attributable to the high-concentration glucose in the PD
solution. The glucose absorbed from peritoneal cavity raises the risk of ‘glucose
toxicity’, leading to insulin resistance and beta cell failure. Clinical similarity can
be found in postprandial hyperglycemia, which is known to be associated with
oxidative stress, endothelial dysfunction, NF-kb, and inﬂammation, affecting
myocardial blood ﬂow. Moreover, it is a proven independent risk factor of
coronary artery disease in patients with type 2 diabetes, particularly of female
gender. Though speculative yet, glucose toxicity might explain a higher
mortality of PD patients after the ﬁrst year compared with those on
hemodialysis (more so in female, advanced-age patients with diabetes). Also
included in the picture are glucose degradation products (GDPs) generated
along the course of heat sterilization or storage of the PD solution. They have
been shown to induce apoptosis of peritoneal mesothelial cells, renal tubular
epithelial cells, and endothelial cells, while spurring production of TGF-b and
VEGF and facilitating epithelial mesenchymal transition. GDPs provide a
stronger reactivity than glucose in the formation of AGEs, a known cause for
microvascular complications and arteriosclerosis. Unfortunately, clinical studies
using a low-GDP PD solution have provided mixed results on the residual renal
function, peritonitis, peritoneal membrane function, and mortality, and
consistent outcome data are hardly available at present.
http://dx.doi.org/10.1016/j.krcp.2012.04.444
Hemodialysis (HD)
Day
1 day Post-HD 2 days Post-HD Normal Controls
Vector Magnitude Daily Average (Counts/Day 7 SD) 3471227 135299 3890777168033 4178707174145 651685758283y
P-Value relative to day of HD (2-tailed) 0.138 0.015* o0.001
Kidney Res Clin Pract 31 (2012) A16–A96A46
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Physical disability is a common result and a major complication after
stroke. The skeletal muscle is the main effector organ accountable for this
disability. Yet, metabolic, structural and functional impairment of muscle
tissue are not recognized as potential targets to improve post-stroke
rehabilitation and remobilisation. We aimed to investigate metabolic and
structural characteristics of the lean tissue as predictors of muscle function in
patients after acute stroke. We studied 40 patients (age 68712y, BMI 2774,
mean7SD) at the beginning of post-stroke hospitalized rehabilitation. All
patients had paretic or plegic deﬁcits of the limb due to acute stroke. Maximum
isometric handgrip strength was measured in the stronger / non-paretic arm by
a dynamometer. Lean tissue characteristics were assessed by whole body
impedance analyses (BIA). Resistance (tissue hydratation, R/H) and reactance
(cell integrity, Xc/H) were assessed and phase angle (phase-a) vector analyses
were performed to evaluate lean tissue quality. Patients were grouped into
tertials for muscle strength (hand grip in tertial 1/2/3: 17.0774.10 N /
28.3372.84 N / 41.2177.97 N). Tertials were similar for BMI and age. Lean
tissue quality measures increased stepwise with muscle strength tertials
(phase-a in tertial 1/2/3: 4.2870.84 / 4.8071.06 / 5.5170.91; ANOVA
p¼0.0064). Univariable regression analysis showed a signiﬁcant association
between muscle strength and tissue structure characteristics (R/H: r¼0.48,
p¼0.0016; phase-a: r¼0.55, p¼0.0002). After multivariable adjustment for
age and BMI, R/H and phase-a remained signiﬁcant predictors of muscle
strength (R/H: joint r¼0.65, p¼0.0009; phase-a: joint r¼0.65, p¼0.0009).
In conclusion, poor lean tissue quality is a major determining factor to predict
muscle strength in patients after stroke. Body impedance is an easy applicable
tool to evaluate tissues metabolic and structural characteristics during post-
stroke rehabilitation. BIA assessments may be helpful to support the rehabili-
tation process of patients after stroke by stressing the aspects of tissue quality.
http://dx.doi.org/10.1016/j.krcp.2012.04.445
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Obesity is associated with increased mortality in the general population, but
with lower mortality in dialysis patients. It is unclear at what stage of CKD this
reversal occurs. Furthermore, it is unclear if associations differ for body mass
index (BMI) or the ponderal index (PI, the weight divided by the third power of
height).
We examined all-cause mortality associated with categories of BMI and PI in
a national cohort of 305,895 US veterans with NDD-CKD and eGFRo60.
Associations were examined in Cox models by CKD stages (3A through 5)
adjusted for demographics, blood pressure and comorbidities.
Patients with BMI 30-o35 had the lowest mortality (Table); mortality was
higher for BMIo30 in all groups. Mortality was higher in patients with
BMI435 in CKD stages 3A-3B, but not in CKD stages 4 and 5. Results were
similar for quintiles of PI (not shown). Obesity is associated with higher
mortality in patients with early/moderate CKD.
In patients with advanced NDD-CKD the highest BMI and PI are associated
with the lowest mortality, similar to dialysis patients. Using a more ideal
measure of obesity (PI) conﬁrms the paradoxical association of obesity with
lower mortality in advanced CKD.
BMI
(kg/m2)
CKD 3A CKD 3B CKD 4 CKD 5
o18.5 3.47
(3.23-3.71)
3.39
(3.08-3.72)
2.92
(2.48-3.46)
2.60
(1.57-4.30)
18.5-o25 1.65
(1.61-1.70)
1.64
(1.58-1.69)
1.52
(1.44-1.62)
1.48
(1.26-1.73)
25-o30 1.12
(1.09-1.15)
1.15
(1.12-1.19)
1.12
(1.06-1.18)
1.24
(1.07-1.44)
30-o35 Referent Referent Referent Referent
4¼35 1.10
(1.06-1.14)
1.10
(1.06-1.15)
0.98
(0.91-1.06)
0.97
(0.78-1.20)
http://dx.doi.org/10.1016/j.krcp.2012.04.446
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Prealbumin, also known as transthyretin, is generally a more sensitive
marker for protein-energy status than albumin and it is reported as an
independent risk for mortality in hemodialysis patients. We evaluated the
association of prealbumin with other markers of nutritional status and
inﬂammation and also the impact of prealbumin on survival in incident PD
patients.
The data of 139 PD patients who started CAPD between January 2002
and November 2007 were analyzed. Laboratory data, dialysis adequacy
and nutritional parameters were assessed at 3 months after PD initiation.
Correlation between prealbumin and other nutritional parameters
and inﬂammation were assessed. Cox proportional hazards regression was
used to identify independent predictors of mortality.
The mean age of patients was 52.7716.0 years (male 62.6%). The
patients with diabetes as a primary renal disease were 46.8%, and 34.6%
of patients had cardiovascular diseases (CVD). The mean duration of
follow-up was 50.0 (range 2-120) months. Prealbumin was positively
correlated with serum Cr, serum albumin, transferrin, % lean body mass
(LBM) and nPCR, but negatively correlated with SGA score, age, hs-CRP and
serum glucose. Mortality was signiﬁcantly higher in low prealbumin (o30
mg/dL) group. In univariate analysis, age, diabetes, presence of CVD, SGA,
low prealbumin (o30mg/dL), high CRP (45 mg/L) were associated with
patient survival. Multivariate analysis demonstrated that older age (age
Z55) (HR 3.002, CI 1.229-7.333), DM (HR 2.936 (1.431-6.026)), CVD (HR
2.902 (1.374-6.130)), high CRP (HR 2.232 (1.150-4.334)) were independent
risk factors of mortality.
In conclusion, prealbumin has a good correlation with other nutritional
markers. Older age, diabetes, CVD, high CRP were independent predictors
for mortality in incident PD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.447
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The eldery constituted the fast growing segment of the end-stage
renal disease (ESRD) population. However, the information about the
elderly patients on hemodilaysis therapy is limited. We investigated
outcomes and the prognostic factors for elderly patients who initiated
hemodialysis.
We reviewed medical recodes and conducted survival analysis in elderly
patients over than 75 years when they had started hemodialysis in single
center between 1988 and 2010. We analyzed the survival time of elderly
hemodialysis patients with Korean national health insurance data system.
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